Revisiting predictors of virologic response to PEGIFN + RBV therapy in HIV-/HCV-coinfected patients: the role of metabolic factors and elevated GGT levels. [electronic resource]
Producer: 20140730Description: 33-41 p. digitalISSN:- 1365-2893
- Adult
- Drug Therapy, Combination -- methods
- Female
- HIV Infections -- complications
- Hepatitis C, Chronic -- diagnosis
- Humans
- Interferon-alpha -- therapeutic use
- Male
- Middle Aged
- Polyethylene Glycols -- therapeutic use
- Prognosis
- Prospective Studies
- Recombinant Proteins -- therapeutic use
- Ribavirin -- therapeutic use
- Treatment Failure
- gamma-Glutamyltransferase -- blood
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.